Literature DB >> 15239399

Case of B-cell lymphoma with rearrangement of the BCL1, BCL2, BCL6, and c-MYC genes.

Keiki Kawakami1, Setsuko Miyanishi, Takashi Sonoki, Shigeo Nakamura, Kenichi Nomura, Masafumi Taniwaki, Tetsuya Murata, Shigenori Kadowaki, Norimitsu Kadowaki, Ikuo Miura.   

Abstract

We managed a peculiar case of lymphoma showing immunohistochemical overexpression of cyclin D1. At initial examination the patient had meningeal lymphomatosis and general lymphadenopathy. Histologic examination of biopsy specimens of inguinal lymph nodes showed tumor cells and vague nodular growth resembling lymphoblasts. The results of flow cytometric analysis were positive for CD10, CD20, CD103, and immunoglobulin G (IgG) and Ig kappa and were negative for CD5, CD23, and terminal deoxynucleotidyl transferase activity. Results of immunohistochemical analysis of paraffin-embedded specimens were positive for cyclin D1 and Bcl2 in the tumor cells. Sixty percent of tumor cells had positive results for MIB1/Ki67. Cytogenetic and molecular studies revealed tumor cells simultaneously had t(14;18)(q32;q21), t(11;22)(q13;q11), t(8;14)(q24;q32), and t(3;14)(q27;q32) with the rearrangement of BCL1, BCL2, BCL6, and c-MYC genes. Lymphadenopathy showed a quick and complete response to doxorubicin-containing systemic chemotherapy with rituximab, but the central nervous system disease progressed and killed the patient.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15239399     DOI: 10.1532/ijh97.03105

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  21 in total

Review 1.  The pathogenetic role of oncogenes deregulated by chromosomal translocation in B-cell malignancies.

Authors:  Martin J S Dyer
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

2.  Immunostaining of PRAD1/cyclin D1 protein as a marker for the diagnosis of mantle cell lymphoma.

Authors:  S Nakamura; Y Yatabe; H Kuroda; R Ueda; T Takahashi; T Suchi; M Seto
Journal:  Leukemia       Date:  1997-04       Impact factor: 11.528

3.  Cloning of human immunoglobulin mu gene and comparison with mouse mu gene.

Authors:  N Takahashi; S Nakai; T Honjo
Journal:  Nucleic Acids Res       Date:  1980-12-20       Impact factor: 16.971

4.  Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression.

Authors:  S Nakamura; M Shiota; A Nakagawa; Y Yatabe; M Kojima; T Motoori; R Suzuki; Y Kagami; M Ogura; Y Morishima; Y Mizoguchi; M Okamoto; M Seto; T Koshikawa; S Mori; T Suchi
Journal:  Am J Surg Pathol       Date:  1997-12       Impact factor: 6.394

5.  B-cell lymphomas with coexpression of CD5 and CD10.

Authors:  Henry Y Dong; Wojciech Gorczyca; Zach Liu; Patricia Tsang; C Daniel Wu; Patti Cohen; James Weisberger
Journal:  Am J Clin Pathol       Date:  2003-02       Impact factor: 2.493

6.  Combination of t(14;18) and a Burkitt's type translocation in B-cell malignancies.

Authors:  A Karsan; R D Gascoyne; R W Coupland; J D Shepherd; G L Phillips; D E Horsman
Journal:  Leuk Lymphoma       Date:  1993-08

7.  Molecular cloning of the breakpoint for 3q27 translocation in B-cell lymphomas and leukemias.

Authors:  T Miki; N Kawamata; A Arai; K Ohashi; Y Nakamura; A Kato; S Hirosawa; N Aoki
Journal:  Blood       Date:  1994-01-01       Impact factor: 22.113

8.  Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease.

Authors:  M Crescenzi; M Seto; G P Herzig; P D Weiss; R C Griffith; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  Detection of t(11;18)(q21;q21) in marginal zone lymphoma of mucosa-associated lymphocytic tissue type on paraffin-embedded tissue sections by using fluorescence in situ hybridization.

Authors:  Kenichi Nomura; Tadashi Yoshino; Satoko Nakamura; Yumiko Akano; Hiroyuki Tagawa; Kazuhiro Nishida; Masao Seto; Shigeo Nakamura; Ryuzo Ueda; Hisakazu Yamagishi; Masafumi Taniwaki
Journal:  Cancer Genet Cytogenet       Date:  2003-01-01

10.  Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation.

Authors:  Y Tsujimoto; E Jaffe; J Cossman; J Gorham; P C Nowell; C M Croce
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

View more
  4 in total

1.  B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Authors:  Matija Snuderl; Olga K Kolman; Yi-Bin Chen; Jessie J Hsu; Adam M Ackerman; Paola Dal Cin; Judith A Ferry; Nancy Lee Harris; Robert P Hasserjian; Lawrence R Zukerberg; Jeremy S Abramson; Ephraim P Hochberg; Hang Lee; Alfred I Lee; Christiana E Toomey; Aliyah R Sohani
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

2.  Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells.

Authors:  Masao Nakagawa; Shinobu Tsuzuki; Keiichiro Honma; Osamu Taguchi; Masao Seto
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

3.  Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.

Authors:  Naoto Tomita; Mami Tokunaka; Naoya Nakamura; Kengo Takeuchi; Junki Koike; Shigeki Motomura; Ko Miyamoto; Ako Kikuchi; Rie Hyo; Yoshihiro Yakushijin; Yasufumi Masaki; Soichiro Fujii; Takamasa Hayashi; Yoshiaki Ishigatsubo; Ikuo Miura
Journal:  Haematologica       Date:  2009-06-16       Impact factor: 9.941

4.  CCND1 Genomic Rearrangement as a Secondary Event in High Grade B-Cell Lymphoma.

Authors:  Jinjun Cheng; Mohamed Amin Hashem; Frederic Barabé; Stéphanie Cloutier; Liqiang Xi; Mark Raffeld; Stefania Pittaluga; Elaine S Jaffe
Journal:  Hemasphere       Date:  2020-12-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.